Biochemical Reagent
-
BA5203 LobradimilSummary: Lobradimil (RMP7), a synthetic form of bradykinin (bradykinin) analog, is a potent and selective bradykinin B2 receptor agonist (0.54 nM). -
BA5204 FulimetibantSummary: A bradykinin receptor antagonist. -
BA5207 LY2828360Summary: LY2828360 is a slow-acting but very potent G protein-biased cannabinoid receptor 2 agonist. -
BA5208 MonlunabantSummary: Monlunabant ((S)-MRI-1891) is a solid dispersion compound. -
BA5209 GW-405833Summary: GW-405833 (L768242) is a potent and selective cannabinoid receptor 2 agonist. -
BA5210 TM38837Summary: 4 (TM38837) is an inverse agonist of cannabinoid receptor 1 is 0.4 nM. -
BA5211 VirodhamineSummary: Virodhamine is an endogenous cannabinoid that regulates neurotransmission by activating cannabinoid (CB) receptors. -
BA5213 TedalinabSummary: Tedalinab (GRC-10693) is a potent, orally active, selective cannabinoid receptor 2 agonist. -
BA5214 VicasinabinSummary: Vicasinabin (RG7774) is a potent agonist of cannabinoid receptor 2. -
BA5215 CB1-IN-1Summary: CB1-IN-1 (BPRCB1184) is a novel peripheral cannabinoid-1 receptor (CB1R) antagonist.

